Literature DB >> 29563204

Frequency of Instrument, Environment, and Laboratory Technologist Contamination during Routine Diagnostic Testing of Infectious Specimens.

Melanie L Yarbrough1, Jennie H Kwon2, Meghan A Wallace1, Tiffany Hink2, Angela Shupe1, Victoria J Fraser2, Erik R Dubberke2, C A Burnham3.   

Abstract

Laboratory testing to support the care of patients with highly infectious diseases may pose a risk for laboratory workers. However, data on the risk of virus transmission during routine laboratory testing conducted using standard personal protective equipment (PPE) are sparse. Our objective was to measure laboratory contamination during routine analysis of patient specimens. Remnant specimens were spiked with the nonpathogenic bacteriophage MS2 at 1.0 × 107 PFU/ml, and contamination was assessed using reverse transcriptase PCR (RT-PCR) for MS2. Specimen containers were exteriorly coated with a fluorescent powder to enable the visualization of gross contamination using UV light. Testing was performed by two experienced laboratory technologists using standard laboratory PPE and sample-to-answer instrumentation. Fluorescence was noted on the gloves, bare hands, and laboratory coat cuffs of the laboratory technologist in 36/36 (100%), 13/36 (36%), and 4/36 (11%) tests performed, respectively. Fluorescence was observed in the biosafety cabinet (BSC) in 8/36 (22%) tests, on test cartridges/devices in 14/32 (44%) tests, and on testing accessory items in 29/32 (91%) tests. Fluorescence was not observed on or in laboratory instrumentation or adjacent surfaces. In contrast to fluorescence detection, MS2 detection was infrequent (3/286 instances [1%]) and occurred during test setup for the FilmArray instrument and on FilmArray accessory equipment. The information from this study may provide opportunities for the improvement of clinical laboratory safety practices so as to reduce the risk of pathogen transmission to laboratory workers.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Ebola virus; contamination; laboratory-acquired infection; risk assessment; sample-to-answer testing

Mesh:

Year:  2018        PMID: 29563204      PMCID: PMC5971558          DOI: 10.1128/JCM.00225-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus.

Authors:  Peter C Iwen; Philip W Smith; Angela L Hewlett; Christopher J Kratochvil; Steven J Lisco; James N Sullivan; Shawn G Gibbs; John J Lowe; Paul D Fey; Vicki L Herrera; Anthony R Sambol; James L Wisecarver; Steven H Hinrichs
Journal:  Am J Clin Pathol       Date:  2015-01       Impact factor: 2.493

2.  An integrated approach to laboratory testing for patients with Ebola virus disease.

Authors:  Peter C Iwen; Jodi L Garrett; Shawn G Gibbs; John J Lowe; Vicki L Herrera; Anthony R Sambol; Karen Stiles; James L Wisecarver; Kathryn J Salerno; Samuel J Pirruccello; Steven H Hinrichs
Journal:  Lab Med       Date:  2014

Review 3.  Approach to Fever in the Returning Traveler.

Authors:  Guy E Thwaites; Nicholas P J Day
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

4.  Laboratory test support for Ebola patients within a high-containment facility.

Authors:  Charles E Hill; Eileen M Burd; Colleen S Kraft; Emily L Ryan; Alexander Duncan; Anne M Winkler; John C Cardella; James C Ritchie; Tristram G Parslow
Journal:  Lab Med       Date:  2014

5.  Viral Contamination Source in Clinical Microbiology Laboratory.

Authors:  Xin Ling Wang; Juan Song; Qin Qin Song; Jie Yu; Xiao Nuan Luo; Gui Zhen Wu; Jun Han
Journal:  Biomed Environ Sci       Date:  2016-08       Impact factor: 3.118

6.  Infections acquired in clinical laboratories in Utah.

Authors:  J T Jacobson; R B Orlob; J L Clayton
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-07-06

Review 8.  Laboratory-associated infections and biosafety.

Authors:  D L Sewell
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Ebola virus disease cluster in the United States--Dallas County, Texas, 2014.

Authors:  Michelle S Chevalier; Wendy Chung; Jessica Smith; Lauren M Weil; Sonya M Hughes; Sibeso N Joyner; Emily Hall; Divya Srinath; Julia Ritch; Prea Thathiah; Heidi Threadgill; Diana Cervantes; David L Lakey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-21       Impact factor: 17.586

10.  Ebola virus disease: The use of fluorescents as markers of contamination for personal protective equipment.

Authors:  Todd Bell; John Smoot; Justin Patterson; Roger Smalligan; Richard Jordan
Journal:  IDCases       Date:  2014-12-24
View more
  3 in total

1.  Application of next generation sequencing technology on contamination monitoring in microbiology laboratory.

Authors:  Yan Xiao; Li Zhang; Bin Yang; Mingkun Li; Lili Ren; Jianwei Wang
Journal:  Biosaf Health       Date:  2019-03-01

Review 2.  Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Authors:  Nancy E Cornish; Nancy L Anderson; Diego G Arambula; Matthew J Arduino; Andrew Bryan; Nancy C Burton; Bin Chen; Beverly A Dickson; Judith G Giri; Natasha K Griffith; Michael A Pentella; Reynolds M Salerno; Paramjit Sandhu; James W Snyder; Christopher A Tormey; Elizabeth A Wagar; Elizabeth G Weirich; Sheldon Campbell
Journal:  Clin Microbiol Rev       Date:  2021-06-09       Impact factor: 50.129

3.  MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.

Authors:  Yi Ding; Jie Yang; Yawen Ma; Tengteng Yao; Xingyu Chen; Shengfang Ge; Lihua Wang; Xianqun Fan
Journal:  J Exp Clin Cancer Res       Date:  2019-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.